Melanoma Vaccines
- 1 March 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (3) , 373-382
- https://doi.org/10.2165/00003495-199447030-00001
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Approaches to Augmenting the IgG Antibody Response to Melanoma Ganglioside VaccinesAnnals of the New York Academy of Sciences, 1993
- Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.Proceedings of the National Academy of Sciences, 1993
- Peptide-Binding Heat Shock Proteins in the Endoplasmic Reticulum: Role in Immune Response to Cancer and in Antigen PresentationAdvances in Cancer Research, 1993
- Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.1992
- A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.The Journal of Experimental Medicine, 1992
- RAC Unanimously Approves Cancer Vaccine TrialJNCI Journal of the National Cancer Institute, 1992
- Gene therapy for cancerThe Lancet, 1992
- Immunocytochemical Analysis of the Cellular Infiltrate in Primary Regressing and Non-Regressing Malignant MelanomaJournal of Investigative Dermatology, 1991
- Western blot analysis of serological responses following immunization with vaccinia viral lysates of melanoma cellsInternational Journal of Cancer, 1990
- Cellular Immune Response Against Autologous Human Malignant Melanoma: Are In Vitro Studies Providing a Framework for a More Effective Immunotherapy?JNCI Journal of the National Cancer Institute, 1990